Загрузка...
Lysophosphatidic acid and its receptors LPA(1) and LPA(3) mediate paclitaxel-induced neuropathic pain in mice
BACKGROUND: Paclitaxel, which is widely used for the treatment of solid tumors, causes neuropathic pain via poorly understood mechanisms. Previously, we have demonstrated that lysophosphatidic acid (LPA) and its receptors (LPA(1) and LPA(3)) are required for the initiation of peripheral nerve injury...
Сохранить в:
| Опубликовано в: : | Mol Pain |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4246549/ https://ncbi.nlm.nih.gov/pubmed/25411045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1744-8069-10-71 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|